Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07129707) titled 'Nasal High-flow Oxygen Therapy During Acute Exercise in Fibrotic Interstitial Lung Disease' on Aug. 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Supportive Care. Masking: Single (Participant).

Primary Sponsor: Dieulefit Sante Centre de Readaptation

Condition: Interstitial Lung Disease (ILD)

Intervention: Other: Exercise testing

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: December 1, 2023

Target Sample Size: 15

Countries of Recruitment: France

To know more, visit https://clinicaltrials.gov/ct2/...